HCID 69744124、化合物 → HCID 135718994、化合物
反応式
C[O:2][C:3](=[O:46])[C:4]1[CH:9]=[CH:8][CH:7]=[C:6]([C:10]2[O:11][C:12]([C:15]3[N:16]([O:38]CC4C=CC=CC=4)[CH:17]([CH:32]4[CH2:37][CH2:36][CH2:35][CH2:34][CH2:33]4)[NH:18][C:19]=3[CH2:20][O:21][C:22]34[CH2:31][CH:26]5[CH2:27][CH:28]([CH2:30][CH:24]([CH2:25]5)[CH2:23]3)[CH2:29]4)=[N:13][N:14]=2)[CH:5]=1.COC(=O)C1C=CC=C(C(N(C(C2N(OCC3C=CC=CC=3)C(C3CCCCC3)NC=2COC23CC4CC(CC(C4)C2)C3)=O)N)=O)C=1>>[C:22]12([O:21][CH2:20][C:19]3[NH:18][CH:17]([CH:32]4[CH2:37][CH2:36][CH2:35][CH2:34][CH2:33]4)[N:16]([OH:38])[C:15]=3[C:12]3[O:11][C:10]([C:6]4[CH:5]=[C:4]([CH:9]=[CH:8][CH:7]=4)[C:3]([OH:46])=[O:2])=[N:14][N:13]=3)[CH2:23][CH:24]3[CH2:30][CH:28]([CH2:27][CH:26]([CH2:25]3)[CH2:31]1)[CH2:29]2参加物
3
実験手順
3-{5-[5-(Adamantan-1-yloxymethyl)-3-benzyloxy-2-cyclohexyl-1H-imidazol-4-yl]-[1,3,4]oxadiazol-2-yl}-benzoic acid methyl ester. The title compound was prepared essentially using the procedure in Example 9, step a, with the modification that 3-{N1-[5-(Adamantan-1-yloxymethyl)-3-benzyloxy-2-cyclohexyl-1H-imidazole-4-carbonyl]-hydrazinocarbonyl}-benzoic acid methyl ester was used instead of 3-{N1-[5-(Adamantan-1-yloxymethyl)-2-cyclohexyl-1H-imidazole-4-carbonyl]-hydrazinocarbonyl}-benzoic acid methyl ester. 1H NMR (CDCl3) 8.77 (1H, s), 8.33 (1H, d), 8.24 (1H, d), 7.63 (1H, t), 7.53 (2H, m), 7.45 (3H, m), 5.37 (2H, s), 4.77 (2H, s), 3.97 (3H, s), 2.73 (1H, m), 2.14 (3H, br s), 1.87-1.56 (19H, m), 1.27 (3H, m).
出典と根拠
- ORDレコード
- ord-8391e8cd4e2c434f97085ddde6b91846
- 出典データセット
- uspto-grants-2005_04
- 特許番号
- US06878734B2
反応ノート
読み込み中…